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Sepsis-associated encephalopathy (SAE) is a brain dysfunction that occurs secondary to infection in the body,
characterized by alteration of consciousness, ranging from delirium to coma, seizure or focal neurological signs.
SAE involves a number of mechanisms, including neuroinflammation, in which the interaction between cytokines
and acetylcholine results in neuronal loss and alterations in cholinergic signaling. Moreover, the interaction also occurs
in the periphery, accelerating a type of immunosuppressive state. Although its diagnosis is not specific in biochemistry
and imaging tests, it could potentiate severe outcomes, including increased mortality, cognitive decline, progressive
immunosuppression, cholinergic anti-inflammatory deficiency, and even metabolic and hydroelectrolyte imbalance.
Therefore, the bilateral communication between SAE and the multiple peripheral organs and especially the immune
system should be emphasized in sepsis management.
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ImmunosuppressionIntroduction
A previously healthy young woman was transferred to
our emergency department 21 days after a third degree
thermal injury involving 35% total body surface area.
She had been well until one week later after the injury,
when a high fever, rapid shallow breathing, excessive
anxiety, and hallucinations occurred. She was found to
be drowsy and confused when roused, with cold and
clammy chin and cyanosis. Her temperature was 38.9°C,
with blood pressure of 67/45 mm Hg, and her white
blood cell count was 14000 per cubic millimeter. After
admission, wound sepsis arising from P. Aeruginosa
infection was confirmed. Since infection can cause similar
neuropsychiatric complications as drugs with anticholinergic
effects [1], the mental condition of this patient prompted
us to undertake an extensive review of the literature
concerning the relationship between infection and
acetylcholine in sepsis induced mental conditions.
With advances in modern intensive care that provide
vital-organ support and better surveillance, especially the
prompt initiation of therapy for the prominent infection,
mortality from severe sepsis and septic shock have been* Correspondence: c_ff@sina.com
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unless otherwise stated.reduced to 20%~ 30% in many reports [2]. With a lowering
of mortality rate, attention has now been focused on the
quality of life among survivors. Numerous studies have
demonstrated that patients who survive sepsis have an
increased risk for poor outcomes in the following months
and years, with significantly pronounced physical and
neurocognitive decline, mental disorders, and long-term
morbidity low quality of life [3]. Abnormalities in cognitive
domains of executive function, attention, and memory
appear to be the most common disorders, and have been
demonstrated to occur as long as 6 years after discharge
from hospital [4].
Increasing evidence indicates that the brain is not
merely a privileged organ in a reversible septic illness,
but is one of the organs profoundly affected in an early
and progressive manner. Sepsis-associated encephalopathy
(SAE) is a brain dysfunction that occurs secondary to
infection in the body without overt central nervous system
(CNS) infection. The severity of SAE may range from mild
delirium to deep coma, and is characterized by changes
in behavior, cognition, awareness, and consciousness.
Therefore, the term sepsis-associated delirium has recently
been proposed to replace the term septic encephalopathy
[1]. Sepsis-associated delirium is one of the most
common causes of delirium in intensive care units (ICU)Ltd. This is an Open Access article distributed under the terms of the Creative
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morbidity and plausibly with diminished long-term
cognitive performance [6].
To date, the complex cascade of molecular and cellular
events, including those leading to septic encephalopathy
after burn injury remain obscure. Furthermore, no effective
therapy has been developed. This review is aiming to dis-
cuss sepsis-induced brain damage and its recent perception
of its pathogenesis, diagnosis, prognosis, sequelae and
possibly effective prevention in critical ill patients.
Epidemiology
Sepsis is one of the leading causes of ICU admissions and
SAE is commonly seen in the ICU [7]. As sedation and
other treatments often obscure its neurological picture, it
might be difficult to recognize delirium in patients with
sepsis. Therefore, its reported incidence varies considerably,
ranging from 8% to 70%, and the variation is at least in part
due to differences in diagnostic criteria.
A recent international survey showed that the prevalence
of delirium was 32.3% in the ICU [8]. The incidence of
encephalopathy is higher in patients who have bacteraemia
and evidence of renal, hepatic or multiorgan failure. 70% of
patients with bacteraemia have neurological symptoms
ranging from lethargy to coma, and >80% of them showed
electroencephalography abnormalities. Patients in the
medical and surgical ICUs are at high risk for long-term
cognitive impairment. In a retrospective study from China
[9], the incidence of SAE was 17.7% in patients admitted
to the ICU over a 3-year period. Acute physiology and
chronic health evaluation II score, heart rate, blood
lactate, serum sodium were significantly higher in the
SAE group than those in non-SAE group. While GCS
scores, platelet counts, serum albumin level, and pH
value were significantly lower in the SAE group [9].
Recently, it was reported that patients with acute lung
injury presented impairment of memory, verbal fluency,
executive function, and cognition in 13%, 16%, 49%, and
55% respectively, of long-term survivors as assessed for
neuropsychological functions at 2 and 12 months after
being discharged from hospital. Depression, post-traumatic
stress disorder, and anxiety were found to be present in 36%,
39%, and 62% of long-term survivors [10]. 6% of patients in
the ICU with respiratory failure or shock showed cognitive
impairment, and delirium developed in 74% of them
during the hospital stay. Three months after being
discharged, 40% of the patients had cognition scores
similar to that of patients with moderate traumatic
brain injury, and 26% had similar scores as that of
patients with mild Alzheimer's disease [5]. Among a
cohort of non-demented elder adults, hospitalization
due to acute care for critical illnesses also showed
greater cognitive decline when compared to that before
hospitalization [11].Burn patients are at high risk of infection, and it is not
surprising that burn injuries are associated with a high
rate of anxiety, depression, and posttraumatic stress
disorder [12]. Disorientation regarding time and place has
often been observed at the early period of burn-associated
sepsis and about two-thirds of burn survivors exhibit a
history of lifetime psychiatric disorders. In a multinomial
regression analysis, the percentage of total body surface
area injured was shown to be an independently and
strongly predicted risk factor for the occurrence of mental
disorders, especially anxiety disorders and delirium
[13]. Burn injury can also induce neural lesions with
microabscess, the release of pro-inflammatory cytokines
from glia cells, the cleavage of structural proteins such as
gelsolin [14], and even apoptosis in the brain [15]. These
events provide the pathological basis for the neuropsychiatric
alterations induced by acute burn insults.
Pathophysiology
Neuroinflammatory processes
Development of SAE probably involves a number of
mechanisms, including hypoxemia, hypotension, glucose
dysregulation, systemic inflammation, reduced cerebral
blood flow, disruption of the blood–brain-barrier, (BBB),
cerebral edema, abnormal neurotransmitter composition,
impaired astrocyte function, and neuronal degeneration.
Neuroinflammation, expressed as frank microglial activation
with excessive expression of immune cytokines based on
brain-immune interactions, is involved in the development
of encephalopathy [16,17]. Systemic inflammation can
produce mild cognitive changes in healthy individuals
[18] and in severe cases (i.e., sepsis/critical illness) it
can trigger delirium [19]. Preliminary studies with brain tis-
sue obtained from 9 patients with delirium was compared
to 6 age-matched controls without delirium, and it was
found that there was an association of human brain activity
of microglia, astrocytes, and IL-6 with delirium in elderly
patients. These results provided evidence that inflammatory
mechanisms to be involved in delirium [20]. SAE may be a
consequence of the activity of inflammatory mediators on
neural cells. For instance, peripheral administration of
lipopolysaccharide (LPS) to mice was found to cause a
rapid and steep rise in TNF-α in the brain that remained
elevated for 10 months [21]. As sepsis in patients was
associated with elevated levels of TNF-α and interleukins
(IL)-1, as well as IL-6 in cerebrospinal fluid, the patho-
physiological mechanisms of SAE may be the result of
a cascade of neuroinflammatory processes as followed.
The first event is an inflammatory process that starts
in the cerebral endothelial lining, which directly releases
or, through alteration of the BBB, facilitates the passage
of inflammatory mediators into the parenchyma. The
exclusively peripheral cytokine signal can be transmitted
to the brain through direct neural pathways (via primary
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circumventricular region, where the BBB is non-existent or
discontinuous [22]. Secondly, immediately upon entering
the cerebral parenchyma, the mediators alter cellular
metabolism by inducing oxidative stress, mitochondrial
dysfunction and microglia activation. This then triggers
neuropathologic abnormalities that range from alterations
in neurotransmission to apoptosis, and finally the
consequent delirium. Moreover, these mediators modulate
β-adrenergic, GABAergic, or cholinergic neurotransmission
and secretion of corticotropin-releasing factor, adrenocorti-
cotropic hormone, and vasopressin [23], affecting the
neuroendocrine pathways and leading to profound
systemic response, which in turn aggravate SAE.
There are now multiple studies in clinical settings which
showed associations between pro-inflammatory cytokines
and delirium, and that a severe systemic inflammation
may more likely produce delirium [24-27]. Prior cognitive
impairment is found to be the major risk factor for delirium,
and such impairment may also be associated with higher
levels of pro-inflammatory cytokines [24]. Another study
found that delirium after surgery was the result of a
dysfunctional neuroinflammatory response [26]. It
may partly be a consequence of decreased levels of
anti-inflammatory mediators rather than exclusively an
excess of pro-inflammatory cytokines [27]. The mechanism
by which the inflammatory mediators produce SAE may be
through interacting with the important neurotransmitter,
acetylcholine (ACh).
Cholinergic-dependent septic encephalopathy: Interaction
between cytokines and acetylcholine in the brain
Neurotransmission mediated by Ach, in particular,
contributes to numerous physiologic functions including
memory, learning, and panic responses. Increasing evidence
indicates that an interaction between cytokines and
acetylcholine is involved in the development of delirium.
Experimental findings show that chronic low dose LPS
infusion in rats results in extensive neuroinflammation
and a substantial reduction in cortical choline acetyltrans-
ferase activity, which is a marker of cholinergic integrity.
In particular, IL-1 inhibits ACh release in vivo in the
hippocampus [28], as well as ACh synthesis in vitro
in cultured pituitary cells [29]. Moreover, IL-1 increases
acetylcholinesterase activity and mRNA expression in
both neuron-glia co-cultures and in the rat cortex in vivo
[30]. One study demonstrated altered behavior and
long-term memory deficits in rats after an injection
of bacterial LPS, which may be indicative of reduced
cholinergic innervation of the cortex, the hippocampus and
the prefrontal cortex [31]. Together, these studies suggest
that both neuronal loss and alterations in cholinergic
signaling induced by LPS or inflammatory cytokines
play potential roles in the long-term effects of SAE.Recent animal studies also indicated that some delirium
might be underpinned by cholinergic hypofunction, per-
haps in combination with dopaminergic overactivity [32].
This hypothesis is based on the effectiveness of an anti-
cholinergic drug treatment to induce delirium in the clinic.
Animal studies further showed that neither animals with
neuronal loss in the cholinergic nucleus, nor normal ani-
mals challenged with LPS showed any deficits on cognition.
However, cholinergic deficient animals, when challenged
with LPS, showed acute and transient working memory
deficits [33]. These deficits could be partially reversed by
the administration of the acetylcholinesterase inhibitor,
indicating that systemic inflammation induced impairments
via disruption of cholinergic signaling. Thus, prior vulner-
ability in the cholinergic system made these animals
susceptible to cognitive impairments induced by LPS.
Similar to what has been noted in the peripheral
tissues, acetylcholine seems to also play a role in control of
brain inflammation as microglia express nicotinic receptors
and activation of these cholinergic receptors attenuates the
pro-inflammatory response [34]. It was not surprising to
find that anticholinergic drugs are recognized as risk factors
for delirium due to a lack of cholinergic anti-inflammatory
effects in the brain [35,36]. Medications with anticholiner-
gic activity negatively affect the cognitive performance in
elderly adults [37], patients with acute stroke, and psycho-
logical patients. Many commonly prescribed drugs have
anticholinergic effects. Systemic side effects, which are
mainly cerebral include visual and tactile hallucinations,
incoherent speech, agitation, disorientation, memory loss,
and acute psychotic reaction have been described. Based on
these observations, it was postulated that systemic inflam-
matory mediators during sepsis damage cholinergic neu-
rons in the hippocampus and frontal lobe, leading to
reduced cholinergic activity on one hand [38], and
impaired cholinergic inhibitory control of microglia on
the other hand. Together, these events contribute to
uncontrolled neuroinflammation leading to delirium
and cognitive decline in the long term.
Microglia plays a crucial role in the innate immune
response of the brain. The pro-inflammatory cytokines
released by microglia exert a vicious cycle of neuroinflam-
mation. On the other hand, activation of the cholinergic
receptors on microglia attenuates the pro-inflammatory
response in vitro [38]. Therefore, we suppose that the
degeneration of cholinergic neurons following SAE impairs
cholinergic inhibitory control of microglia, further exacer-
bating neuroinflammation in SAE.
Septic encephalopathy with immunosuppressive status:
Interaction between cytokines and acetylcholine in the
periphery
The brain senses and modulates the systemic inflammatory
response through the neural circuits of vagus nerve via the
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gic neural output has been shown to modulate innate
immune response to infection, injury and ischemia
through both the release of acetylcholine at the distal
vagus nerve acting on macrophages and the connection of
the vagus nerve with the spleen via the splenic sympathetic
nerve (Figure 1). On one hand, vagus nerve stimulation
promotes the release of the acetylcholine, which in turn
inhibits the systemic inflammatory response by reducing
the production of the pro-inflammatory cytokines in
human endotoxin-stimulated macrophages [39]. On the
other hand, recent evidence indicates that the vagus nerve
could also activate adrenergic neurons in the spleen. The
neurotransmitters (norepinephrine, epinephrine) released
by the vagus nerve promote splenic T cells to secrete
ACh, which in turn interacts with α7 nicotinic ACh
receptors (nAChR) on monocytes and thereby inhibit
pro-inflammatory cytokine production [41]. Expression of
α7 nAChR on other immune cells, including polymorpho-
nuclear neutrophils, dendritic cells (DC), NK cells, B cells,
T cells as well as endothelial cells, fibroblasts, and synovio-
cytes provides a wide range of opportunities for the brain
to modulate tissue response to injury [40].
Systemic inflammatory mediators are recruited into
the brain via the disrupted blood–brain barrier and
circumventricular organs, and activate the microglia to
produce more cytokines as termed “neuroinflammation”.
The consequent cytokines can induce neural apoptosis
of cholinergic neuron, which in turn reduces cholinergic ac-
tivity by decreasing the level of cholinergic neurotransmitterFigure 1 Interactions of cytokines with acetylcholine in the central ne
peripheral consequences.acetylcholine. Cholinergic hypofunction can lead to delirium,
cognitive decline, vagus anti-inflammatory deficiency and
reduced cholinergic inhibition of activated microglia. The
vagus anti-inflammatory deficiency prompts augmented
pro-inflammatory response; while the accelerated activated
microglia initiates higher levels of cytokines and which in
turn activate the hypothalamus-pituitary-adrenal (HPA)
axis to release glucocorticoid hormone, and sympathetic
nervous system (SNS) to release the catecholamine, both of
which lead to immunosuppressive response. The simulta-
neously occurrence of the enhanced pro-inflammatory and
immunosuppressive responses subsequently exacerbate the
infection and worsen the outcome.
Accumulating evidence suggested that the “inflammatory
reflex arc” might be activated in the situation of encephal-
opathy. It was recently reported that pathogens can rapidly
activate vagal afferent and efferent signaling and cause
pronounced bradyarrhythmias [42]. More data suggests
that an increase in vagal tone is expected to decrease
inflammatory cytokines [43,44] and catecholamines, reduce
ability to clear parasitism [43], as well as lower heart rate
variation suppression in a rat sepsis model [44]. Secondly,
the intimate interaction between cytokines and acetyl-
choline in sepsis might reduce the innate immune re-
sponse during early stages, but if it persists, the consequent
enhanced inflammatory reflex would result in immunosup-
pression. Therefore, immunoparalysis observed in later
sepsis may, at least in part, results from enhanced
vagal activity and subsequent sustained effects of the
cholinergic anti-inflammatory pathway [45]. Additionalrvous system that induces septic encephalopathy and its
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way in the context of encephalopathy comes from a clinical
trial of an acetylcholinesterase inhibitor to treat ICU
delirium. The trial was based on the dual role of
acetylcholine as a neuromodulator as well as an endogenous
inhibitor of systemic inflammatory response to endotoxemia
[46]. Unexpectedly, the trial was stopped early because of
increased mortality in the treatment group [47]. The
possible mechanism for the harmful outcome might
due to the accelerated immunoparalysis caused by the
enhanced cholinergic anti-inflammatory activity with
acetylcholinesterase inhibitor in previous immuno-
suppressed patients with critical illness. More evi-
dence is critically needed to support this hypothesis.
Clinical features and diagnosis
The importance of SAE is frequently dismissed, as it is
seen as a transient entity. Nevertheless, SAE is often
suspected in patients presenting with acutely altered
mental status accompanied by severe sepsis or septic
shock. The severity of SAE can range from mild delirium to
deep coma. They might show disturbances in sleep-wake
cycles or evidence of hallucinations, restlessness or agitation,
among other symptoms commonly seen in delirium.
Moreover, 70% of advanced cases of SAE have an associated
critical illness neuromyopathy. In case of burn injury,
patients mainly presented with early psycho-motor ex-
citement, characterized by delirium and disorientation,
logorrhea, sleeplessness, and loss of self-recognization,
Recently, diffuse and severe white matter abnormalities
were present in severe encephalopathy with extensive white
matter lesions, though in a reversible condition. Imaging of
the brain may show atrophy and periventricular white
matter lesions, abnormal low density of the whole white
matter with swelling of the entire brain [48]. Thus, SAE
remains largely a clinical diagnosis. However, a myriad of
abnormalities are seen in patients with SAE, including
abnormalities in laboratory tests. A comprehensive meta-
bolic panel of analyses including a complete blood count,
measurement of electrolytes and serum enzyme levels, renal
function tests, and investigations for infection are required
to determine whether the patient has an infection or an
anatomical abnormalities [49]. Sepsis-associated delirium
was diagnosed using the confusion assessment method in
the ICU. For practical purposes, the confusion assessment
method for patients outside the ICU was advocated by
Young GB [49]. Considering that SAE is an early feature of
systemic infection that presents before a satisfactory criteria
for sepsis is established, the clinical manifestations of SAE
can be detected before presentation of strong evidence of
sepsis or systemic inflammatory response syndrome (SIRS).
Although no specific biomarker exists for SAE, several
potential biomarkers could be considered. Markers such
as neuron-specific enolase (NSE), S100β and glial fibrillaryacidic protein (CNS), and their presence in serum reflects
CNS injury. Children with sepsis had higher levels of
serum NSE, S100 β and GFAP than that of controls, and
serum levels of both NSE and S100 β were highest in
children who did not survive sepsis [50]. Similar findings
have been demonstrated in adults, with 42% of 170
patients with sepsis showing an increase in serum
S100 β levels, and 53% of patients showing an increase in
serum NSE levels during the first 72 hours after hospital
admission [51]. A study showed that increased serum
levels of IL-8 were associated with delirium in patients
with inflammation, whereas IL-10 and amyloid β levels
were elevated in patients with noninflammatory delirium
[25]. Patients with inflammatory delirium, who later showed
cognitive impairment, had acutely elevated amyloid β levels.
Systemic elevations in serum procalcitonin and IL-6 levels
were also seen in patients with severe sepsis [52]. However,
neither procalcitnonin nor IL-6, is a specific biomarker for
CNS injury. Taken together, the above-mentioned studies
support the hypothesis that SAE is, in fact, a result of direct




Meta-analysis has provided evidence that delirium in
elderly patients is associated with an increased risk of death,
institutionalization, and dementia, independent of age, sex,
comorbidity, illness severity, and presence of dementia.
Mortality is almost always due to multi-organ failure rather
than neurological complications. The persistence of the
association between delirium and poor outcome years after
the occurrence of delirium and presumably resolution of
the precipitating factors suggests that delirium is not
merely a marker of underlying disease [6]. In fact, delirium
was found to precede the overt diagnosis of sepsis in 30.8%
of patients, thus suggesting that delirium might serve as a
precursor of the development of sepsis [53], therefore, an
increased mortality is expected.
Cognitive decline
Mounting evidence in both animal models and in human
studies, suggests that substantial long-term cognitive
sequelae are associated with SAE. Animal models have
shown long-term changes in behavior, learning and
memory following SAE [31]. A longer duration of delirium
in the hospital was independently associated with long-
term cognitive outcomes [54] and worse global cognition as
well as executive function scores at 3 and 12 months [5].
Of great importance, longer duration of delirium was
recently found to be associated with smaller brain
volumes up to 3 months after discharge, and that
smaller brain volumes are associated with long-term
cognitive impairment up to 12 months [55].
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SAE could lead to progressive immunosuppression
possibly by activating sympathetic nerve system, and par-
tially hypothalamic pituitary adrenal (HPA) axis, resulting
in uncontrolled infection and vicious cycle with SAE.
Additional evidence indicates that sepsis in the later stages
can be associated with a state of immunosuppression,
broadly defined as lymphopenia and loss of immune
function, reflected by the down-regulation of monocytic
human leukocyte antigen (HLA)-DR expression, ex vivo
TNF-α production and elevated plasma IL-10 in parallel
[45,56]. It was clearly revealed that the sympathetic
nervous system (SNS) especially β-adrenergic receptors
and HPA axis were involved in cerebral trauma-induced
immunodepression via a mechanism of apoptotic cell
death [57]. For instance, experimental stroke induces
alterations in the immune system and their outcome
via and the SNS [58]. Postoperative release of pro-
inflammatory cytokines into the cerebrospinal fluid
without any signs of systemic inflammation was associated
with immunodepression and an increased risk of infections
in neurosurgical patients [59]. Direct evidence proved that
the pro-inflammatory cytokines such as IL-1β in the brain
and cerebral inflammation may trigger a systemic anti-
inflammatory condition without preceding systemic
inflammation [60]. Persistence of this phenomenon
increases the risk for infectious complications. Further
clinical and experimental results indicate that pro-
inflammatory cytokines produced by damaged brain
tissue can directly lead to HPA and SNS activation
[61]. Elevated levels of cytokines, such as IL-1β, TNF-α,
and IL-6, have been measured after stroke in brain
parenchyma and cerebrospinal fluid. Because the autonomic
system of the CNS is “hard-wired” with secondary lymphoid
organs, interruption of these circuits can result in immune
dysfunction. Therefore, multiple causes including the
“non-specific” stress response, CNS injury-specific neuro-
genic signaling, and local CNS inflammation have to be
considered as triggers of systemic immunodepression [62].
The neuropathology in SAE is quite similar to that of
patients with stroke and traumatic brain injury in terms
of elevated levels of pro-inflammatory cytokines in the
brain. It prompts us to hypothesize that these cytokines in
SAE could also mediate immunosuppression in a similar
manner as in brain injury. The irreversible compromised
immunity occurred later in severe sepsis could also be the
consequence of SNS and HPA activation.
Cholinergic anti-inflammatory deficiency
Although the “inflammatory reflex arc” might be activated
in the situation of encephalopathy to clear pathogen,
SAE in the long term might reduce cholinergic anti-
inflammatory activity due to the lack of cholinergic
neurotransmission by ACh, resulting in an augmentedpro-inflammatory response. Inflammatory reflexes have
been proposed as a pathway to facilitate resolution of
inflammation triggered by infection, ischemia, or sterile
injury and a mechanism of rapid and localized control of
immunity [63]. During the early stages of the immune
response, the vagus nerve transmits tonic inhibitory
activity that attenuates innate responses to injury and
the activation of effector cells [64], but when it persists over
time, it can lead to immunosuppression which exacerbates
SAE. Although clinical studies have not established a causal
relationship between depressed vagal nerve signaling and
sepsis, lower tonic vagal activity has been associated with
decreased capacity to resolve inflammation and with
increased morbidity as well as mortality in inflammatory
states such as severe sepsis and myocardial infarction [65].
In contrast, inhibition of brain acetylcholinesterase,
which causes the increase of Ach could theoretically
suppress systemic inflammation through a central muscarinic
receptor-mediated and vagal- and α7 nAChR- dependent
mechanism [66]. We suppose that at later stages of SAE, the
vagus nerve transmitter, acetylcholine, would be decreased
due to the neural apoptosis, thus attenuated vagal activity
might potentiate a pro-inflammatory response due to
the lack of the intrinsic cholinergic anti-inflammatory
mechanism.
Metabolic and hydroelectrolyte imbalance
Last but not the least, since the CNS could regulate the
metabolic and hydroelectric balance, the impairment
of neurological function in SAE could also lead to the
refractory hyperglycemia [67] and hypernatremia [68]
in sepsis.
It is increasingly appreciated that CNS controls the
metabolic and electrolyte balance. Reduced CNS insulin
signaling from either defective secretion or action,
contributes to the pathogenesis of common metabolic
disorders, including diabetes and obesity. The hypothalamic
IKKβ/nuclear factor kappaB (NF-κB) pathway is a general
neural mechanism for the energy imbalance underlying
obesity. Forced activation of hypothalamic IKKβ/NF-κB
interrupts central insulin/leptin signaling and action, while
its suppression significantly protects against obesity and
glucose intolerance [69] Hyperglycemia in the ICU has
been linked with worse outcomes [70], moreover, NF-κB
activity is significantly elevated in adults and children
with severe sepsis [71].The impaired insulin signaling
and activation of NF-κB prompts us to hypothesize that
SAE could also result in metabolic and hydroelectrolyte
imbalance.
Disturbances in fluid and electrolytes are among the
most common clinical problems encountered in the ICU.
Hypernatraemia develops in the ICU because various
factors promote renal water loss. For example, relative
vasopressin deficiency is seen in approximately one-third
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traemia is an independent predictor of mortality [72]. In
burn patients, hypernatremia, but not hyponatremia, is an
independent predictor of mortality [73]. The possibility
for SAE might lead to the disturbance of fluid and electro-
lytes is that SAE could damage the crucial brain regions
regulating the balance of fluid and electrolytes. It was
appreciated that dysfunction of the hypothalamus, pituitary,
or adrenal glands is a common secondary cause for sodium
or water imbalance as a result of trauma, tumors, or inflam-
mation. Moreover, a recent study found that hypernatremia
is relevant to the sodium-level-sensing mechanism in the
brain, as a patient with autoantibody directed against Nax
channel in the brain had essential hypernatremia [74].
Therefore, SAE may disrupt the central sodium-level sensor
of body fluids in the brain, making the patients prone
to developing hypernatremia.
Perspectives
Currently, patients with septic encephalopathy receive
supportive therapy and therapy for the underlying disease
without intervention targeted to the cause of the
encephalopathy. Several aspects deserve to be emphasized,
in particular the interaction of the development of
encephalopathy with the peripheral multiple organ including
immune system dysfunction. An improved understanding
on the cause of septic encephalopathy would lead to the
development of new specific therapy options in the future.
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